Cannabis Law Report

NOVEMBER 13, 2021

A cardiologist with no public comments on cannabinoid therapies, Dr. Robert Califf, has been nominated to take over as commissioner of the U.S. Hemp Today reports. Food and Drug Administration. President Joe Biden made the nomination Friday, calling Califf a “steady, independent hand.”. More at [link].

Cannabinoids 52

Cannabinoids Therapy Pharmaceutical Hemp 52

Cannabis Law Report

DECEMBER 9, 2021

08, 2021 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. He has published over 300 peer reviewed publications and supervised fourteen higher degrees. Moreau CEO of Algernon Pharmaceuticals Inc. “We About Algernon Pharmaceuticals Inc. . Algernon Pharmaceuticals Inc. Published: Dec 08, 2021. Christopher J.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

SpeedWeed

APRIL 9, 2021

Last year, researchers from Rice University’s Baker Institute for Public Policy undertook a new study in order to “gain insight into the needs and experiences” of the state’s medical pot users. The post 61% of Medical Cannabis Users in Texas Said Weed Helped Them Get off Pharmaceuticals appeared first on SpeedWeed.

Pharmaceutical 52

Pharmaceutical Chronic Pain Programs Patients 52

Cannabis Law Report

JULY 23, 2019

(TSXV: LG and OTC-QB: LGGCF) (“ LGC ”) is pleased to announce that it has paid the 2 nd Tranche, as contractually agreed, in acquiring an equity interest in the Italian pharmaceutical company, Freia Farmaceutici Srl (“Freia”). This EU pharmaceutical entity is an optimal addition to LGC. LGC Capital Ltd.

Pharmaceutical 45

Pharmaceutical Seed-To-Sale Compliance Compliance 45

Cannabis Law Report

APRIL 21, 2022

Publication of this process establishes “prior art,” contributing to MAPS’ patient access strategy by making intellectual property public . The manufacture methods of MDMA at a laboratory scale were originally placed in the public domain by Alexander Theodore Shulgin, Ph.D., Ann Shulgin, and David E. Nichols, Ph.D.,

Clinical Trials 52

Clinical Trials Research and Development Therapy Media 52

Cannabis Law Report

OCTOBER 26, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, announced today that Chris Chapman, M.D., Chapman has operated Chapman Pharmaceutical Consulting, Inc., About MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

Cannabis Life Network

JUNE 16, 2023

Since cannabis can’t cause a fatal overdose and appears relatively benign (compared to most pharmaceutical drugs), public health busybodies had to find a new angle. That’s been the mantra of the modern cannabis temperament movement. Ergo, high THC levels cause psychosis. Potent cannabis can disconnect you from reality.

THC 109

THC Pharmaceutical Marijuana Cannabis 109

Cannabis Law Report

JUNE 21, 2020

This is Money (UK) reports Geoffrey Guy, who founded GW Pharmaceuticals in 1998, made £5.8m last year GW’s chief executive Justin Gover pocketed an eye-watering … Read More.

Pharmaceutical 59

Pharmaceutical 59

Cannabis Law Report

JULY 2, 2021

Dr. Rungpetch Sakulbumrungsilp Dean of the Faculty of Pharmaceutical Sciences, Chulalongkorn University. Dr. Rungpetch Sakulbumrungsilp, Dean of the Faculty of Pharmaceutical Sciences, Chulalongkorn University, unlike the present in which many facets and aspects of cannabis are being studied in addition to the work of Chula C.A.N.S.,

Research and Development 105

Research and Development Pharmaceutical Extraction Seed-To-Sale 105

Cannabis Law Report

NOVEMBER 5, 2019

Cabot Wealth Management Inc increased its stake in Gw Pharmaceuticals Plc (GWPH) by 34.2% The institutional investor held 20,865 shares of the major pharmaceuticals company at the end of 2019Q2, valued at $3.60M, up from 15,548 at the end of the previous reported quarter. based on its latest 2019Q2 regulatory filing with the SEC.

Pharmaceutical 45

Pharmaceutical Epilepsy Treatment Medicine 45

Cannabis Law Report

SEPTEMBER 8, 2021

The platform was specifically designed to power the traceability of testing standards within the legal cannabis, nutraceutical, food and pharmaceutical space with a focus on the authentication of source materials or ingredients used in formulation. Public Relations Contact: Cassandra Dowell. +1 About Applied DNA Sciences Inc.

Supply Chain 95

Supply Chain Pharmaceutical Seed-To-Sale Events 95

Cannabis Law Report

JULY 9, 2022

Mayle is wanted after being accused of the supply of MDMA, methylphenidate (a pharmaceutical drug) and diazepam, and fled after being charged. He allegedly ran a drug line in south London and Surrey called the Flavour Quest, working with a dark web drug dealer buying and selling drugs including LSD and pharmaceutical medications.

Pharmaceutical 52

Pharmaceutical Sleep 52

Cannabis Law Report

MAY 30, 2019

(CSE: BBT) (FSE: BBW) (OTC Pink: BHHKF) (“Benchmark”, “BBT” or the “Company”) a federally-licensed producer and distributor of medical-grade cannabis, is pleased to report that it has signed a definitive agreement with China-based Zhejiang Yatai Pharmaceutical Co.,

Pharmaceutical 40

Pharmaceutical Research and Development Extraction Cultivation 40

Puff Puff Post

MARCH 10, 2020

SOURCE InMed Pharmaceuticals Inc. About InMed: InMed Pharmaceuticals is a clinical stage pharmaceutical company developing a pipeline of cannabinoid-based medications, initially focused on the therapeutic benefits of cannabinol (CBN) in diseases with high unmet medical need.

Clinical Trials 40

Clinical Trials Pharmaceutical Research and Development Cannabinoids 40

Veriheal

JULY 26, 2023

Eligible patients registered with the state’s Department of Public Health can purchase cannabis oil from Georgia’s independent pharmacies. The first batch of authorized pharmaceutical retailers is expected to start selling between late August and early September.

Oil 97

Oil Patients Access THC 97

Cannabis Law Report

JANUARY 13, 2020

12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020. Enquiries: GW Pharmaceuticals plc.

Pharmaceutical 66

Pharmaceutical Clinical Trials Research and Development Programs 66

Cannabis Law Report

JUNE 5, 2019

Press Release: Thailand Government Pharmaceutical Organization. The Pharmaceutical Organization, Department of Medical Affairs, signed a joint research on standard quality medical marijuana extracts for patients with chemo-allergic cancer, epilepsy, muscle contraction in patients with deteriorating nerve sheaths. Google Translation.

Pharmaceutical 40

Pharmaceutical Extraction Epilepsy Research and Development 40

Cannabis Law Report

MARCH 7, 2023

Benzinga report 6 March An investor is publicly suing Tilray Brands Inc , the Canadian pharmaceutical and cannabis company and one of the most popular cannabis stocks out there.

Pharmaceutical 59

Pharmaceutical Legalization Cannabis Law 59

MMJ Recs

NOVEMBER 17, 2023

The community impact is visible in several key areas: Healthcare Advancements MMJ has expanded the range of treatment options available to patients, offering an alternative to conventional pharmaceuticals. It has improved the quality of life for those dealing with chronic pain, nausea, seizures, and other medical conditions.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

Project CBD

JULY 28, 2023

Scialdone, a recognized expert in the field of organic chemistry who specializes in natural product chemistry, is an inventor of 37 issued US patents and the author of 17 peer-reviewed articles in science publications. From 1994 to 2013, he was employed as a principal investigator at DuPont Central Research and Development.

THC 212

THC Cannabinoids Hemp Research and Development 212

Cannabis Law Report

JULY 31, 2020

Asia One reports… The Ministry of Public Health has agreed to blend marjuana with pharmaceutical formulas to prescribe in local health promotion hospitals. The ministry … Read More.

Medicine 86

Medicine Pharmaceutical Cannabis 86

Cannabis Law Report

NOVEMBER 19, 2021

Securities and Exchange Commission (the “SEC”) relating to a proposed initial public offering of its common stock. The initial public offering is expected to take place after the SEC completes its review process and is subject to market and other conditions.

Seed-To-Sale 52

Seed-To-Sale Events Cultivation Conditions 52

Cannabis Law Report

NOVEMBER 19, 2021

Securities and Exchange Commission (the “SEC”) relating to a proposed initial public offering of its common stock. The initial public offering is expected to take place after the SEC completes its review process and is subject to market and other conditions.

Seed-To-Sale 52

Seed-To-Sale Events Cultivation Conditions 52

Cannabis Law Report

AUGUST 7, 2021

About MAPS Public Benefit Corporation (MAPS PBC). Founded in 2014, MAPS PBC is a Public Benefit Corporation that prioritizes public benefit over profit. Why work for MAPS Public Benefit Corporation (MAPS PBC)? Full Job Description. Position Requirements. Specific experience with UK or Germany preferred.

Clinical Trials 105

Clinical Trials Research and Development Compliance Compliance 105

Cannabis Law Report

JULY 7, 2021

A public cannabis company with a strong focus on the international market is stepping into Mexico’s nascent medical cannabis industry. Some companies aiming to create products can import cannabis plant material, according to the news source.

Pharmaceutical 105

Pharmaceutical Cannabinoids Cultivation Concentrates 105

Cannabis Law Report

JANUARY 20, 2022

II (“SPKB”) (NASDAQ: SPKB/SPKBU/SPKBW), a publicly traded special purpose acquisition company (“SPAC”) sponsored by an affiliate of Silver Spike Capital (“Silver Spike”), announced today that they have signed a definitive business combination agreement expected to make Eleusis a public company.

Therapy 52

Therapy Research and Development Business Access 52

Cannabis Law Report

NOVEMBER 9, 2021

As described in the publication, the use of LinearDNA, coupled with non-viral transfection systems, we believe, overcomes many of the existing manufacturing complexities associated with pDNA and viral vectors, thereby offering therapy developers a rapid and cost-effective tool for manufacturing preclinical CAR T cells. Join our mailing list.

Clinical Trials 52

Clinical Trials Research and Development Therapy Supply Chain 52

Cannabis Chronicles

APRIL 2, 2019

regulators are planning a public hearing to collect more information on CBD in cosmetics, foods and other products as the cannabis compound spreads in popularity. The FDA has approved a pharmaceutical version of CBD to treat rare seizure disorders. NEW YORK — U.S. CBD comes from marijuana or hemp plants but does not cause a high.

CBD 113

CBD Food Pharmaceutical Collective 113

MGC Pharma

MARCH 13, 2018

MXC’s fourth division: MGC Nutraceuticals MGC Pharmaceuticals will be taking its first step into the world of nutraceuticals with the creation of our new brand, MGC Nutraceuticals. MGC Nutraceuticals will allow us to create more dynamic products that, unlike MGC Pharma products, don’t require a prescription, and can be sold anywhere, anytime.

Pharmaceutical 100

Pharmaceutical Conditions CBD eCommerce 100

Cannabis Law Report

MARCH 29, 2022

On March 8, MAPS Public Benefit Corporation (MAPS PBC) announced that Michael Mullette, an experienced drug development and commercialization expert, has joined its senior leadership team as Chief Operating Officer. Mullette joins MAPS PBC after more than 20 years in the pharmaceutical industry. They write. He holds a B.S.

Therapy 52

Therapy Pharmaceutical Clinical Trials Access 52

Cannabis Law Report

JUNE 17, 2021

This landmark investment and strategic transaction solidifies Brains’ position as one of the leading pharmaceutical companies in the cannabinoid (CBD) sector. To have the confidence of DSM in this next round solidifies Brains strategic position within the pharmaceutical industry,” said Brains’ CEO & Chairman Rick Brar.

Pharmaceutical 105

Pharmaceutical Clinical Trials Research and Development Events 105

MGC Pharma

APRIL 4, 2018

A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals. UPDATE: CannEpil™ production has officially commenced was originally published in MGC Pharmaceuticals on Medium, where people are continuing the conversation by highlighting and responding to this story. CannEpil™?—?CBD-based

Epilepsy 100

Epilepsy Pharmaceutical Research and Development CBD 100

Cannabis Law Report

NOVEMBER 17, 2021

The National Pharmaceutical Regulatory agency (NPRA) approved Sativex in 2014 for patients experiencing muscle spasms and spasticity from multiple sclerosis. Earlier in November, The Public Health Ministry in Thailand has just signed an agreement with Rx Leaf World Medica to establish an international medical cannabis research centre.

Research and Development 111

Research and Development Patients Treatment Pharmaceutical 111

Veriheal

DECEMBER 15, 2023

MAPS Public Benefit Corporation (PBC), an arm of the Multidisciplinary Association for Psychedelic Studies , has made big strides recently encouraging the Food and Drug Administration (FDA) to consider approving MDMA, also known as molly or ecstasy, for MDMA-assisted therapy.

Therapy 89

Therapy Decriminalization Treatment Pharmaceutical 89

Cannabis Law Report

SEPTEMBER 10, 2021

Brazilian pharmaceutical company Prati-Donaduzzi, whose 20 year patent to produce CBD oil was recently revoked, offers an alternative to imported products—even though it is manufactured with imported raw material.

Policy 103

Policy Oil Concentrates Pharmaceutical 103

SpeedWeed

SEPTEMBER 17, 2021

One of the company’s owners previously worked in the pharmaceutical market and wanted to enter the cannabis industry to provide an alternative form of relief to patients, Brodsky says. Polling looks good, so I think we’re going to be all right,” he says. View original article.

Environment 79

Environment Dispensary Retail Education 79

Cannabis Law Report

AUGUST 6, 2021

MAG would control licensing for the import and reproduction of cultivation seeds with the Costa Rican Social Security Fund (CRSS), which is reponsible for most of the country’s public health sector, or authorized laboratories or entities.

Hemp 105

Hemp Programs Agriculture Environment 105